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httpOutcomes of endovascular and contemporary open
surgical repairs of popliteal artery aneurysm
Ying Huang, MD, PhD,a Peter Gloviczki, MD,a Gustavo S. Oderich, MD,a Audra A. Duncan, MD,a
Manju Kalra, MBBS,a Mark D. Fleming, MD,a William S. Harmsen, MS,b and Thomas C. Bower, MD,a
Rochester, Minn
Objective: The purpose of this study was to compare outcomes after endovascular repair (ER) and contemporary open
repair (OR) of popliteal artery aneurysms (PAAs).
Methods: Clinical data of PAA patients treated between 2005 and 2012 were reviewed. Primary end points were major
adverse events (MAEs) including mortality, major amputation, patency, complications, and reinterventions.
Results: A total of 149 PAAs were treated in 120 patients (mean age, 74 6 10 years). ER was performed in 42 limbs of 35
men (mean age, 816 6.5 years), in 32 electively and in 10 emergently. Technical success was 98%. The 30-day MAEs were
more frequent after emergent repair (50% vs 9%; odds ratio [OR], 9.67; 95% conﬁdence interval [CI], 1.74-54; P[ .01);
mortality and amputation rate was 0% after elective repair, 20% after emergent repair. Mean follow-up was 2.6 years (1
month-6.5 years); 3-year freedom from MAEs was lower after emergent repair than after elective repair (40% vs 66%;
hazard ratio [HR], 3.13; 95% CI, 1.10-8.85; P [ .03). OR was performed in 107 limbs of 91 patients (90 men; mean
age, 71 6 9.6 years), in 93 electively and in 14 emergently. The 30-day MAEs were more frequent after emergent repair
(43% vs 5%; OR, 13; 95% CI, 3.29-53; P < .001); mortality was 1% after elective repair, 0% after emergent cases.
Amputation rate was 0% for both elective and emergent repairs. Mean follow-up was 3.8 years (1 month-8.4 years);
3-year freedom from MAEs was lower after emergent repair (50% vs 80%; HR, 3.78; 95% CI, 1.55-9.20; P[ .003). The
30-day MAE rates were equivalent between ER and OR independent of urgency of repair (elective: OR, 1.82; 95% CI,
0.41-8.09; P [ .43; emergent: OR, 1.33; 95% CI, 0.26-6.81; P [ .73). In elective interventions, ER had a trend to
decreased freedom from MAEs (66% vs 80% at 3 years; HR, 1.93; 95% CI, 0.92-4.07; P [ .08); freedom from rein-
tervention was lower after ER (72% vs 88%; HR, 2.41; 95% CI, 1.02-5.70; P[ .046). In emergent interventions, 1-year
freedom from MAEs was similar (40% vs 50%; HR, 1.36; 95% CI, 0.49-3.74; P [ .55). Emergent ER and poor runoff
predicted MAEs.
Conclusions:Our study failed to prove the superiority of ER over OR. If anatomy is suitable, ER of PAA in the elderly and
high-risk patients is justiﬁed. For emergent PAA repairs, MAEs are frequent after both ER and OR; ER has not changed
the severe prognosis of acute limb ischemia from PAA. A multicenter randomized controlled trial of PAA patients with
acute presentation is warranted. (J Vasc Surg 2014;60:631-8.)Popliteal artery aneurysms (PAAs) are rare but account
for approximately 70% of all peripheral artery aneurysms,
with a prevalence of <0.01% reported in hospitalized pa-
tients.1 Although more than half of the PAAs are asymp-
tomatic, they have been referred to as ‘‘the silent killer’’
because of the devastating thromboembolic events they
can cause, resulting in the major amputation rate up to
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://dx.doi.org/10.1016/j.jvs.2014.03.257can be associated with complication rates of 15% to 25%
at 1 year and 60% to 75% at 5 years.8,9
To prevent complications of PAA, open repair (OR)
with endoaneurysmorrhaphy and great saphenous vein
(GSV) bypass has been accepted as the “gold standard,”
with 5-year patency rate of 93% and limb salvage rate of
100% after asymptomatic PAA repairs.2 Since the ﬁrst
report of endovascular repair (ER) of a PAA in 1994,10
advances in endovascular techniques and technology have
made ER an attractive alternative to OR because of its
minimally invasive technique, shorter operative time, and
reduced hospital stay.5,11-18 Technical success rates range
from 94% to 100% and primary patency rates are 75% to
94% at 1 year and 59% to 87% at 2 years, with limb salvage
rates of 85% to 100%.7,15,17,19 We performed our ﬁrst ER
in 2004. Results of our early experience at 1 year with 31
procedures were reported.20
Recent population-based outcome analysis of the Cen-
ters for Medicare and Medicaid inpatient claims identiﬁed
an increase in ER of PAA from 12% in 2005 to 24% in
2007; however, ER was associated with a higher reinter-
vention rate than OR (12% vs 7% at 90 days). ER did
not offer a mortality or cost beneﬁt.11 Some authors17 re-
ported similar midterm reintervention, patency, and limb631
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is still unknown. The purpose of this study was to compare
outcomes after ER and OR of PAA at a tertiary center.
METHODS
The clinical data of consecutive PAA patients treated at
Mayo Clinic, Rochester, Minnesota, between January 1,
2005, and June 30, 2012, were retrospectively reviewed.
Demographics, clinical and operative data, early and late
patency, major amputation, morbidity, reintervention,
and mortality were recorded. Patients were grouped by
the type of intervention (ER or OR) and the urgency of
repair (elective or emergent).20 Primary end points were
major adverse events (MAEs) including mortality, major
amputation, patency, complications, and reinterventions.
Complications included cardiac, pulmonary, renal, and
neurologic events,21 and reinterventions included those
performed within and after 30 days of index surgery. The
study was approved by the Mayo Foundation Institutional
Review Board.
A PAA was deﬁned as focal dilation of the popliteal ar-
tery by >50% above the maximum normal diameter (0.9 6
0.2 cm), as an external diameter measured with ultrasonog-
raphy, computed tomography, or magnetic resonance
angiography.2 Clinical categories for both acute and
chronic limb ischemia and criteria for patency were identi-
ﬁed as recommended by Rutherford et al.22
Indications. Indications for intervention included
acute limb ischemia with a salvageable limb, PAAs with
compressive symptoms or chronic limb ischemia, asymp-
tomatic PAA with aneurysm >2 cm, and mural thrombus
or evidence of previous thromboembolism.2,23 Mural
thrombus prompted repair or lowered the size threshold for
repair in our series when patients had evidence of previous
thromboembolism or when patients presented with acute
limb ischemia or blue toe syndrome caused by a PAA. For
ER, proximal and distal neck of the aneurysm with a length
of >15 mm and at least one-vessel runoff were required.
Lack of thrombus at the landing zones and overall geometry
were important. Because tapered stent grafts are not avail-
able, a difference of more than 4 mm in diameter between
the proximal and distal landing zones precluded stenting.
Stent grafts were oversized 1 or 2 mm, and stents were
overlapped by a minimum of 4 cm. Patients with
age <50 years, poor runoff, or symptoms of compression
and those who were active and frequently ﬂexed the knee
>90 degrees were not candidates for ER.5,19,20 Preoperative
catheter-directed thrombolysis (CDT) with tissue plasmin-
ogen activator (tPA) was performed in patients with grade I
or IIa acute limb ischemia.22
Procedure. OR included endoaneurysmorrhaphy,
proximal and distal ligation of the popliteal artery or exci-
sion of the aneurysm, and reconstruction with interposition
or bypass with autologous or prosthetic graft through a
medial or posterior approach.2 ER included exclusion of
the PAA with use of a Viabahn stent graft through an
ipsilateral common femoral artery cutdown or percuta-
neous access on the basis of the surgeon’s preference.20 ForCDT, percutaneous femoral access was obtained with ul-
trasound guidance, followed by insertion of the fenestrated
infusion catheter within the thrombosed arterial
segment.20
Postoperative medication. Double antiplatelet therapy
of clopidogrel (300 mg) and acetylsalicylic acid (325 mg)20
or anticoagulation with warfarin was initiated on the opera-
tive day for patients with ER or polytetraﬂuoroethylene
(PTFE) bypass graft and continued for 3 months or lifetime,
depending on the surgeon’s preferences.
Follow-up. Patients were asked to return at 1 to
3 months after intervention for physical examinations and
studies with ankle-brachial indices, duplex ultrasound im-
aging, and selective computed tomography angiography
and at every 6 months afterward. Pulse examination for
patency was recorded, but patency rates were based on
imaging studies. Follow-up information was obtained from
the medical records and mailing questionnaires. Patient
vital status was established from charts, mailing question-
naire, death certiﬁcate, or autopsy report.
Deﬁnitions. In patients with ER, technical success was
deﬁned as complete exclusion of the aneurysm with no
signs of endoleak after balloon dilation of the stent graft
with preservation of distal runoff. Endoleak was deﬁned
as radiographic evidence of blood ﬂow outside the stent
graft; types of endoleak were deﬁned as described in Soci-
ety for Vascular Surgery practical guidelines.24 Conversion
surgery was deﬁned as OR in a patient who was intended to
undergo endograft placement but in whom successful
deployment failed or for failure of an endograft.20
Statistical analysis. Descriptive statistics are reported
as number (percentage) or mean (standard deviation) as
appropriate. The association of a patient or surgical variable
with the odds of 30-day outcome was assessed by logistic
regression. Results are reported as odds ratio (OR) and
95% conﬁdence interval (CI). Survival was estimated with
the Kaplan-Meier method and included all outcomes after
surgery. Patient and surgical variable association with the
risk of midterm outcome was assessed by a Cox propor-
tional hazards model. Correlated PAAs within some pa-
tients were accounted for in these models. For MAE, a
multiple variable Cox model was also examined. Results of
these models are reported as hazard ratio (HR) and 95%
CI. The a level was set at .05 for statistical signiﬁcance.
Analyses were performed with SAS 9.2 software (SAS
Institute, Inc, Cary, NC).
RESULTS
Patient population. During the study period, 217 pa-
tients were diagnosed with 271 PAAs. Of these, 70 with 86
PAAs were not recommended surgery, 21 with 29 PAAs
refused surgery, four underwent surgery elsewhere, and
one with bilateral PAAs underwent repair after completion
of this study. One patient died of lung cancer before repair
of PAA. A total of 149 PAAs were treated in 120 patients
(male: 119; 99%), with a mean age of 74 years (range,
45-92 years). Of the 120 patients, 70 (58%) had bilateral
PAAs. Forty-two limbs of 35 male patients (mean age,
Table I. Demographics and comorbidities of 120 patients with 149 popliteal artery aneurysm (PAA) repairs
ER OR
Elective
(n ¼ 25),
No. (%)
Emergent
(n ¼ 10),
No. (%)
Overall
(N ¼ 35),
No. (%)
Elective
(n ¼ 77),
No. (%)
Emergent
(n ¼ 14),
No. (%)
Overall
(N ¼ 91),d
No. (%)
Male 25 (100) 10 (100) 35 (100) 76 (99) 14 (100) 90 (99)
Age, years, mean 6 SD
median (ranges)
80 6 6.4
80 (64-91)
86 6 4.2a
88 (75-89)a
81 6 6.5
82 (64-91)
72 6 9.2b
73 (49-92)b
69 6 12b
71 (45-88)b
71 6 9.6c
73 (45-92)c
Bilateral PAA 15 (60) 4 (40) 19 (54) 48 (62) 7 (50) 55 (60)
Concomitant AAA 19 (76) 8 (80) 27 (77) 43 (56) 6 (43) 49 (54)c
Cardiac 6 (24) 6 (60) 12 (34) 7 (9) 1 (7)b 8 (9)c
Hypertension 19 (76) 9 (90) 28 (80) 55 (71) 10 (71) 65 (71)
Hyperlipidemia 20 (80) 8 (80) 28 (80) 57 (74) 10 (71) 67 (74)
COPD 3 (12) 5 (50)a 8 (23) 12 (16) 1 (7) 13 (14)
Chronic renal insufﬁciency 0 (0) 1 (10) 1 (3) 3 (4) 0 (0) 3 (3)
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; ER, endovascular repair; OR, open repair; SD, standard deviation.
aP < .05 emergent vs elective within ER or OR.
bP < .05 OR vs ER within elective or emergent repairs.
cP < .05 overall OR vs ER.
dP: six of these 91 patients underwent ER in the other limb.
Table II. Clinical data of 149 popliteal artery aneurysms
(PAAs)
ER
(n ¼ 42),
No. (%)
OR
(n ¼ 107),
No. (%)
Overall
(N ¼ 149),
No. (%)
Size, cm, mean 6 SD 3.0 6 0.9 3.2 6 1.5 3.1 6 1.4
Symptom
Asymptomatic 29 (69) 56 (52) 85 (57)
Acute 12 (29) 15 (14) 27 (18)
Ischemia 12 (100) 14 (93) 26 (96)
Rupture 0 (0) 1 (7) 1 (4)
Chronic 1 (2) 36 (34) 37 (25)
Runoff 144 (100)
0 1 (2) 4 (4) 5 (4)
1 13 (31) 26 (25) 39 (27)
2 19 (45) 39 (38) 58 (40)
3 9 (21) 33 (32) 42 (29)
ER, Endovascular repair; OR, open repair; SD, standard deviation.
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patients (90 men; mean age, 71 6 9.6 years) were treated
with OR, including six who had ER in one limb and OR in
the other. Patients with ER were 10 years older than those
with OR (81 6 6.5 vs 71 6 9.6 years; P < .001) and had
cardiac comorbidities more frequently (P < .05; Table I).
Clinical characteristics. Mean aneurysm diameter was
3.1 6 1.4 cm (range, 1.4-9.0 cm), measured by duplex ul-
trasonography (n ¼ 106), computed tomography or
computed tomography angiography (n ¼ 42), and mag-
netic resonance angiography (n ¼ 1). Eighty-ﬁve PAAs
(57%) were asymptomatic, 26 (17%) had acute ischemia,
and 37 (25%) had chronic symptoms including 32 (86%)
chronic ischemia. Runoff vessels were assessed in 144
(97%) limbs. There were no differences between ER and
OR in terms of aneurysm size, the distribution of symp-
toms, and runoff vessels (Table II).
Intraoperative data. Of 42 ERs, 32 (76%) were elec-
tive, 10 (24%) were emergent; of 107 ORs, 93 (87%) were
elective, 14 (13%) were emergent. CDT was initiated in 20
lower limbs with acutely thrombosed PAAs (ER: 100%, 10
of 10; OR: 71%, 10 of 14). Of 149 PAA repairs, there were
37 (26%) concomitant procedures, more frequently done
with emergent repairs (P < .05) (Supplementary Table I,
online only).
Of 42 ERs, a mean of 2.1 Viabahn stents (range, 1-4
stents) per limb were implanted; mean treated length was
19 6 5.3 cm. There was one conversion to OR, and tech-
nical success was achieved in 41 limbs (98%). Operative
time was doubled for emergent ER vs elective ER
(263 6 191 vs 131 6 53 minutes; P < .001). Of 107
ORs, there were 86 (80%) autogenous vein grafts and 21
(20%) PTFE grafts. Operative time was signiﬁcantly
decreased for emergent OR vs elective OR (287 6 75 vs
3546 91 minutes, P ¼ .01). Elective ER had shorter oper-
ative time than OR (P < .001); emergent ER had similar
operative time (P ¼ .68).Thirty-day outcomes. Both intensive care unit (ICU)
stay and hospitalization were increased for emergent repairs
independent of the type of repair. In elective repairs, hospi-
talization was prolonged after OR vs ER (4.2 6 2.7 vs
1.9 6 0.5 days; P < .001); in emergent repairs, ER had
increased ICU stay compared with OR (4.6 6 3.9 vs
1.6 6 1.6 days; P ¼ .02).
Of 149 PAA repairs, there were 19 (13%) MAEs;
30-day MAE rate was higher for emergent repairs than
for elective repairs within ER (52% vs 9%; OR, 6.35; 95%
CI, 1.55-31; P ¼ .01) or within OR (43% vs 5%; OR,
9.80; 95% CI, 2.94-34; P < .001) and equivalent between
ER and OR within elective repairs (OR, 1.82; 95% CI,
0.37-7.41; P ¼ .43) or within emergent repairs (OR,
1.43; 95% CI, 0.41-4.76; P ¼ .56). There were nine
(6%) early reinterventions; four grafts (3%) thrombosed
early, three (30%) occurred after emergent ER, and one
(1%) occurred after elective OR (Table III). Three patients
Table III. Thirty-day outcomes after 149 popliteal artery aneurysm (PAA) repairs
ER OR
Elective
(n ¼ 32),
No. (%)
Emergent
(n ¼ 10),
No. (%)
Overall
(N ¼ 42),
No. (%)
Elective
(n ¼ 93),
No. (%)
Emergent
(n ¼ 14),
No. (%)
Overall
(N ¼ 107),
No. (%)
MAE 3 (9) 5 (50)a 8 (19) 5 (5) 6 (43)a 11 (10)
Mortality 0 (0) 2 (20) 2 (5) 1 (1) 0 (0) 1 (1)
Complications 4 (13) 8 (80)a 12 (29) 26 (28) 9 (64)a 35 (33)
Systemic 2 (6) 7 (70)a 9 (21) 5 (5) 3 (21) 8 (8)
MI 1 (3) 3 (30)a 4 (10) 3 (3) 1 (7) 4 (4)
Renal 1 (3) 2 (20) 3 (7) 1 (1) 0 (0) 1 (1)
Wound 1 (3) 2 (20) 3 (7) 19 (20)b 5 (36) 24 (22)c
Graft thrombosis 0 (0) 3 (30)a 3 (7) 1 (1) 0 (0) 1 (1)
Reintervention 1 (3) 4 (40)a 5 (12) 1 (1) 3 (21)a 4 (4)
Major amputation 0 (0) 2 (20) 2 (5) 0 (0) 0 (0) 0 (0)
ER, Endovascular repair; MAE, major adverse event; MI, myocardial infarction; OR, open repair.
aP < .05 emergent vs elective within ER or OR.
bP < .05 OR vs ER within elective or emergent repairs.
cP < .05 overall OR vs ER.
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ter emergent ER, and one of 93 patients (1%) died after
elective OR. The causes of death were acute on chronic
renal failure, myocardial infarction, and sustained intracra-
nial hemorrhage after successful preoperative CDT, respec-
tively, in one patient each. There were two early major
amputations (1%), including one with early death at
3 days, both after emergent ER (20%), with patient’s age
>85 years and zero or one-vessel runoff, respectively,
seen in each limb after CDT.
All-cause complications and reintervention were more
frequent after emergent repair independent of type of
intervention. Wound complications were more frequent af-
ter OR; systemic complications, myocardial infarction, and
graft thrombosis were more frequent after emergent ER
compared with elective ER (Table III).
Midterm outcomes
Mean follow-up was 2.6 years (range, 1 month-
6.5 years) for patients with ER and 3.8 years (range, 1
month-8.4 years) for OR.
Freedom from MAE. For ERs, the estimated 3-year
freedom from MAE was lower for emergent repairs than
for elective repairs (40% vs 66%; HR, 3.13; 95% CI, 1.10-
8.85; P ¼ .03). For ORs, it was lower for emergent repairs
than for elective repairs (50% vs 80%; HR, 3.78; 95% CI,
1.55-9.20; P ¼ .003). In comparison of ER with OR, in
elective interventions, there was a trend toward decreased
freedom from MAE rate after ER (66% vs 80%; HR, 1.93;
95% CI, 0.92-4.07; P ¼ .08); in emergent interventions,
these rates were similar (40% vs 50%; HR, 1.36; 95% CI,
0.49-3.74; P ¼ .55) (Fig 1).
Univariate analysis revealed that ER, emergent repair,
and runoff (zero or one-vessel vs two-vessel vs three-
vessel) were each signiﬁcant predictors for MAE, whereas
there was no signiﬁcant association for age and aneurysm
size (Supplementary Table II, online only). In the multiplevariable model including runoff and the four-level type of
procedure for association with the risk of MAE, the vessel
runoff was signiﬁcant (P ¼ .009) and the type of procedure
was borderline signiﬁcant (P ¼ .07; Table IV).
Patency. For ERs, the estimated 3-year primary patency
rate was lower for emergent repairs than for elective repairs
(54% vs 75%;HR, 3.90; 95%CI, 1.08-14;P¼ .04; Fig 2). For
ORs, rates were not signiﬁcantly different (77% vs 85%; HR,
2.07; 95% CI, 0.77-5.54; P ¼ .15; Supplementary Fig 1,
online only). In comparison of ER with OR, in elective in-
terventions, these rates were similar (75% vs 85%; HR, 2.01;
95% CI, 0.88-4.59; P ¼ .10); in emergent interventions, ER
had a trend toward decreased primary patency (54% vs 86%;
HR, 2.95; 95% CI, 0.78-11; P ¼ .11). Primary patency was
similar between Viabahn stent grafts and PTFE grafts (69% vs
78%; HR, 1.72; 95% CI, 0.64-4.61; P ¼ .28).
For ERs, the estimated 3-year secondary patency rates
were similar between emergent and elective repairs (79% vs
83%%; HR, 2.99; 95% CI, 0.61-15; P ¼ .18). For ORs,
they were not signiﬁcantly different (84% vs 93%; HR, 3.32;
95% CI, 0.88-13; P ¼ .08; Supplementary Fig 2, online
only). In comparison of ER with OR, these rates were similar
in elective interventions (83% vs 93%; HR, 2.57; 95% CI,
0.78-8.45; P ¼ .12) and in emergent interventions (79% vs
93%; HR, 1.96; 95% CI, 0.40-9.68; P ¼ .41). Secondary
patency was similar between Viabahn stent grafts and PTFE
grafts (81% vs 82%; HR, 1.48; 95% CI, 0.39-5.59; P ¼ .56).
Freedom from reintervention. By the time of last
follow-up, there were 32 reinterventions. Of the 14 rein-
terventions after ER, there were four conversion surgeries
due to chronic occlusion of the popliteal stent graft with
critical limb ischemia (n ¼ 2), post failed thrombectomy of
the superﬁcial femoral artery and the stent graft for acute
Rutherford IIa limb ischemia (n ¼ 1), and persistent type
II endoleak (n ¼ 1); causes of the remaining 10 reinter-
ventions were graft thrombosis (n ¼ 6), type I endoleak
(n ¼ 2), infolding of the stent graft (n ¼ 1), and wound
Fig 1. Freedom from major adverse event (MAE) of 149 popliteal
artery aneurysm (PAA) repairs according to type of intervention.
A, Endovascular repair (ER) vs open repair (OR) in 125 elective
interventions. B, ER vs OR in 24 emergent interventions. Dashed
lines, number at risk <10.
Table IV. Multivariable analysis of factors predicting
major adverse events (MAEs)
Variable HR (95% CI) P value Overall P value
Type of surgery .07
Elective OR 1.0 (reference)
Emergent OR 1.68 (0.60-4.71) .32
Elective ER 2.08 (0.98-4.40) .06
Emergent ER 3.18 (1.09-9.29) .03
Runoff .009
3-vessel 1.0 (reference)
2-vessel 1.53 (0.58-4.09) .39
0 or 1-vessel 3.97 (1.43-11) .008
CI, Conﬁdence interval; ER, endovascular repair; HR, hazard ratio; OR,
open repair.
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causes were graft/anastomosis stenosis (n ¼ 7), graft
thrombosis (n ¼ 5), wound infection (n ¼ 3), graft
infection (n ¼ 1), contained rupture of proximal anasto-
mosis (n ¼ 1), and major amputation (n ¼ 1).
For ERs, the estimated 3-year freedom from reinter-
vention rate was lower for emergent than for elective re-
pairs (48% vs 72%; HR, 3.61; 95% CI, 1.13-11; P ¼
.03). For ORs, it was lower for emergent than for elective
repairs (57% vs 88%; HR, 4.95; 95% CI, 1.90-13; P ¼
.001). In comparison of ER with OR, in elective interven-
tions, ER had signiﬁcantly decreased freedom from reinter-
vention rate than OR (72% vs 88%; HR, 2.41; 95% CI,
1.02-5.70; P ¼ .046); in emergent interventions, these
rates were similar (48% vs 57%; HR, 1.41; 95% CI, 0.46-
4.33; P ¼ .54) (Supplementary Fig 3, online only).
Limb salvage. Four months after elective OR per-
formed for Rutherford class V critical limb ischemia, a
reversed GSV popliteal-peroneal graft thrombosed and
the patient underwent a below-the-knee amputation. The
estimated 3-year limb salvage rate was 99% for this sub-
group. No amputation was performed after emergent OR,
and there was no late amputation after ER.Survival. A total of 21 deaths occurred during follow-
up. The estimated 3-year survival rate was lower for
emergent ER than for elective ER (40% vs 83%; HR, 9.71;
95% CI, 3.06-30; P < .001). However, the rates were
equivalent after OR (90% vs 92%; HR, 1.46; 95% CI, 0.48-
4.40; P ¼ .50).
DISCUSSION
Our previous study of OR of 358 PAAs performed
before 2004 demonstrated that elective OR with saphe-
nous vein graft resulted in no limb loss and had a 5-year
primary patency of 93%. For emergent PAA repairs, early
mortality was 4%, with amputation rate of 8%; GSV grafts
had 5-year primary patency of 78%.2 Currently, OR of
PAAs with endoaneurysmorrhaphy and autologous bypass
is considered to be the gold standard,2,3,18,25,26 although
PTFE interposition graft, inserted through a posterior
approach, has also been popular.27
In this contemporary series, outcomes after OR were
similar to those reported previously.2,3,18,25,26 Emergent
OR was associated with prolonged ICU stay and hospital
stay, increased rate of MAEs including higher rate of early
complications, and reinterventions. Patients after OR had
no early limb loss, but there was an early mortality of 1%
after elective repair. Emergent OR had more adjunctive
procedures, including thrombectomies and fasciotomies,
than elective OR. PTFE grafts had a 3-year primary
patency of 78%. We used PTFE grafts in limbs with good
runoff (62%), and nearly half were heparin-bonded PTFE
grafts. At our institution, currently about 30% of patients
with PAAs undergo ER, a number similar to national
trends reported for the United States.11,16,18,20 The early
beneﬁts of ER in terms of hospital stay, complications
related to anesthesia, and invasiveness of the procedure
are obvious5,13; however, the durability, especially after
emergent repair, remains unknown. Emergent ER in our
study resulted in increased hospital stay, a 20% mortality,
and a 20% amputation rate. Early complications and graft
thrombosis, early and late reinterventions, and MAEs
were signiﬁcantly more frequent after emergent ER than
after elective ER. Emergent ER also had decreased primary
patency (54%) at 1 year compared with elective ER.
Fig 2. A,Magnetic resonance arteriogram of a 4.1-cm left popliteal artery aneurysm (PAA) of an 85-year-old man. B,
Computed tomography angiogram shows widely patent stent grafts (two) and thrombosed PAA at 6.5 years. This
patient required balloon angioplasty at 3.2 years because of stent infolding.
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only prospective randomized trial comparing OR with ER
was reported by Antonello et al,5 who observed similar 1-
year primary patencies (100% vs 87%). Noticeably, only
asymptomatic patients were enrolled in this study, with
only 15 patients in each treatment arm; 28% of the ORs
had below-knee prosthetic grafts. Three-year patency rates
in this study were also similar, 71% for OR and 88% for
ER.13 In a multicentric retrospective study from Italy
that included 178 ORs and 134 ERs, Pulli et al17 reported
no early mortality after OR and 1.5% after ER; each treat-
ment group had one amputation; 2-year secondary
patency, freedom from reintervention, and limb salvage
rates were similar (77% vs 85%, 73% vs 75, 90% vs 97%;
P > .05). Symptomatic PAAs, acute limb ischemia, and
runoff score <2, which were conﬁrmed risk factors predict-
ing loss of primary patency, were more frequent in OR than
in ER; 63% of the ORs were performed with prosthetic
grafts. Stone et al16 also reported similar 3-year primary
patency and survival rates between ER and OR (64% vs
73%; 65% vs 81%). In the population-based study of
2962 Medicare and Medicaid Services inpatients, overall
complication rates for OR and ER were similar (11% vs
9%); however, ER was associated with more reinterventions
(at 90 days, 12% vs 7%; P < .001) and did not offer a mor-
tality or cost beneﬁt.11
Consistent with the literature,5,13,17 3-year MAE and
patency rates after elective ER and OR were similar in
our study, although ER had more reinterventions. Emer-
gent ER and poor runoff predicted MAEs.PAAs with acute presentation usually have high ampu-
tation rates, 8% early and 15% late in our previous study.
However, in this series, there was no amputation after
emergent OR of 13 limbs with acute ischemia. This may
be explained by the small sample size; by frequent use of
thrombolysis (n ¼ 10), thrombectomy (n ¼ 4), and fasciot-
omy (n ¼ 4); and by use of GSV bypass (n ¼ 9) or arm vein
graft (n ¼ 1). Although the 30-day amputation rate after
emergent ER was 20% in this study, because of the small
size, this was not signiﬁcantly different from amputation
rate after OR.
Preoperative CDT with tPA is now routinely per-
formed in limbs with acute thromboembolism to improve
runoff.2,17,28 Pulli et al17 observed a complication rate of
12%, with one of ﬁve patients developing severe thrombo-
cytopenia. Thrombolysis-related complication rates were
20% after ER (n ¼ 2) and 30% after OR (n ¼ 3) in this
study, including one fatal complication of intracranial
bleeding; three of ﬁve patients required reoperation for
bleeding. The possibility of bleeding complications should
be discussed with the patient before initiation of tPA. We
check ﬁbrinogen levels at 4-hour intervals and discontinue
lytic treatment if the ﬁbrinogen level drops by 50% from
baseline level or if the ﬁbrinogen level is <100 mg/dL.29
Our retrospective and nonrandomized study, per-
formed in a small group of patients, has all limitations of
such studies. Patients with ER had a small sample size,
they were older, and they had more cardiac comorbidities;
younger, active patients and those with poor runoff were
preferentially treated with OR. These may falsely result in
JOURNAL OF VASCULAR SURGERY
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sity score analysis to decrease selection bias was not per-
formed. ER patients had shorter follow-up, which may
have inﬂuenced outcome assessment because many of these
patients are still prone to development of stent graft-related
complications and may need reinterventions. Because of
the small number in some subgroups, results of emergency
repairs cannot be generalized, and a type II error is also
likely.
CONCLUSIONS
Our study failed to prove the superiority of ER over
OR. For elective PAA repairs, ER was inferior in outcomes
because there was a trend for more MAEs, and ER was fol-
lowed by signiﬁcantly more reinterventions than OR.
However, 3-year patency rates were similar after ER and
OR. If anatomy is suitable, however, elective ER in the
elderly and high-risk patients still seems to be justiﬁed.
For emergent PAA repairs, ER and OR were equivalent.
MAEs were equally frequent, and ER has not changed
the severe prognosis of acute limb ischemia from PAA. A
multicenter randomized controlled trial of PAA patients
with acute presentation is clearly warranted.
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Supplementary Fig 1 (online only). Primary patency of 149 popliteal artery aneurysm (PAA) repairs according to
urgency of intervention. A, Elective vs emergent endovascular repairs in 42 limbs. B, Elective vs emergent open repairs
in 107 limbs. Dashed lines, number at risk <10.
Supplementary Fig 2 (online only). Secondary patency of 149 popliteal artery aneurysm (PAA) repairs according to
urgency of intervention. A, Elective vs emergent endovascular repairs in 42 limbs. B, Elective vs emergent open repairs
in 107 limbs. Dashed lines, number at risk <10.
Supplementary Fig 3 (online only). Freedom from reintervention of 149 popliteal artery aneurysm (PAA) repairs
according to type of intervention. A, Endovascular repair (ER) vs open repair (OR) in 125 elective interventions. B,
Endovascular repair (ER) vs open repair (OR) in 24 emergency interventions. Dashed lines, number at risk <10.
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Supplementary Table I (online only). Operative data of 149 popliteal artery aneurysm (PAA) repairs
ER OR
Elective
(n ¼ 32),
No. (%)
Emergent
(n ¼ 10),
No. (%)
Overall
(N ¼ 42),
No. (%)
Elective
(n ¼ 93),
No. (%)
Emergent
(n ¼ 14),
No. (%)
Overall
(N ¼ 107),
No. (%)
General anesthesia 18 (56) 6 (60) 24 (57) 93 (100)b 14 (100)b 107 (100)c
Thrombolysis 0 (0) 10 (100) 10 (24) 0 (0) 10 (71) 10 (9.3)
Preoperative d 9 (90) 9 (21) d 9 (90) 9 (8.4)
Intraoperative d 2 (20) 2 (5) d 1 (10) 1 (1)
Access/approach
Percutaneous 11 (34) 3 (30) 14 (33) d d d
Femoral cutdown 21 (66) 7 (70) 28 (67) d d d
Medial d d d 81 (87) 13 (93) 94 (88)
Posterior d d d 12 (13) 1 (7) 13 (12)
Type of surgery
Endoaneurysmorrhaphy d d d 51 (55) 5 (36) 56 (52)
Ligation d d d 39 (42) 8 (57) 47 (44)
Excision d d d 3 (3) 1 (7) 4 (4)
Graft
Viabahn 32 (100) 10 (100) 42 (100) d d d
Heparin-bonded 23 (72) 6 (60) 29 (69) d d d
Number of stent grafts used 2.0 6 0.9 2.3 6 0.5 2.1 6 0.8 d d d
Treated length 19 6 5.5 20 6 5.0 19 6 5.3 d d d
Autogenous d d d 76 (82) 10 (71) 86 (80)
GSV d d d 71 (93) 9 (90) 80 (94)
SSV d d d 3 (4) 0 (0) 3 (3)
Other vein d d d 2 (3) 1 (10) 3 (3)
PTFE d d d 17 (18) 4 (29) 21 (20)
Concomitant procedure 7 (22) 6 (60)a 13 (31) 17 (18) 7 (50)a 24 (22)
Fasciotomy 0 2 (20) 2 (5) 1 (1) 4 (29)a 5 (5)
Operative time, minutes 131 6 53 263 6 191a 163 6 115 354 6 9b 287 6 75a 345 6 92c
ER, Endovascular repair; GSV, great saphenous vein; OR, open repair; PTFE, polytetraﬂuoroethylene; SSV, small saphenous vein.
Values for number of stent grafts used and operative time are mean 6 standard deviation.
aP < .05 emergent vs elective within ER or OR.
bP < .05 OR vs ER within elective or emergent repairs.
cP < .05 overall OR vs ER.
Supplementary Table II (online only). Univariate analysis of risk factors predicting major adverse events (MAEs) in 149
limbs with popliteal artery aneurysm (PAA)
Variable No. 3-year freedom from MAE, % (95% CI) HR (95% CI) P value Overall P value
Age, per 5 years 149 d 1.08 (0.94-1.25) .26
Size of PAA, per 1 cm 148 d 1.15 (0.92-1.44) .22
Type of intervention .03
OR 107 76 (68-85) 1.0 (reference)
ER 42 59 (45-77) 1.96 (1.07-3.61)
Urgency of repair <.001
Elective 125 77 (69-85) 1.0 (reference)
Emergent 24 45 (29-71) 3.73 (1.90-7.33)
Runoff <.001
3-vessel 42 88 (79-98) 1.0 (reference)
2-vessel 58 78 (68-91) 1.75 (0.67-4.58) .25
0 or 1-vessel 44 48 (35-66) 4.82 (1.93-12) <.001
Type of surgerya <.001
Elective OR 93 80 (72-89) 1.0 (reference)
Emergent OR 14 50 (30-84) 3.71 (1.54-8.93) .004
Elective ER 32 66 (50-86) 1.88 (0.91-3.87) .09
Emergent ER 10 40 (19-85) 6.28 (2.27-17) <.001
CI, Conﬁdence interval; ER, endovascular repair; HR, hazard ratio; OR, open repair.
aWithin ER, emergent relative to elective: HR (95% CI) ¼ 3.34 (1.12-9.91), P ¼ .03; within OR, emergent relative to elective: HR (95% CI) ¼ 3.71 (1.54-
.91-3.87), P ¼ .08; within emergent, ER relative to OR: HR (95% CI) ¼ 1.69
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8.93), P ¼ .004; within elective, ER relative to OR: HR (95% CI) ¼ 1.88 (0
